June 22, 2020 / 1:05 PM / 11 days ago

BRIEF-Pfizer Announces Start Of Four Phase 3 Clinical Trials For Investigational Vaccines

June 22 (Reuters) - Pfizer Inc:

* PFIZER ANNOUNCES START OF FOUR PHASE 3 CLINICAL TRIALS FOR INVESTIGATIONAL VACCINES

* PFIZER - INITIATION OF TWO STUDIES OF 20VPNC, EVALUATING A FOUR-DOSE SERIES IN INFANTS STARTING AT 2 MONTHS OF AGE

* PFIZER - INITIATION OF ONE STUDY OF RESPIRATORY SYNCYTIAL VIRUS VACCINE CANDIDATE, RSVPREF

* PFIZER - INITIATION OF ONE STUDY OF PENTAVALENT MENINGOCOCCAL VACCINE CANDIDATE, MENABCWY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below